Good Shrink. Bad Shrink

Article

ShrinkRap's Dinah reflects on comments given to a previous post on texting with patients.

The following was originally posted to ShrinkRap.

Over time, I've noticed some trends among our blog commenters. Some readers comment on the content of our posts, others link us to Viagra spam, and finally, some readers talk directly to us. We hear about their own experiences of the topic we've blogged about, or simply about their day. This is good, though I could do with a little less Viagra or AirJordan spam in my life.

Sometimes readers inject enough of themselves into their comments that it becomes clear they have opinions about us, the Shrink Rappers, feet, ducks and all. Sometimes it seems like readers are poised to like us, and other times it feels like readers are lying in wait, looking to attack. I was particularly struck by the comments people made on my post about The Texting Shrink. Rachel says I have a kind-heart and another commenter (?--I think it was Retriever) noted that I do this to increase my availability to patients. Dr. Steve put it bluntly: I am an idiot! I hope I do have a kind heart, but I text with patients because I've found this to be to my convenience--- it's a quicker way to deal handle brief messages, and none of it's about being more available. My life is better if I get a "stuck in traffic" text and know I have time to run to the restroom or eat a snack. And if a patient needs me to phone a pharmacy or return a call, it's so much quicker to click on the texted number than it is to re-listen to my messages and try to decipher that phone number 6 times by replaying voicemail -- and oh, I don't have a pen and can I memorize it quickly enough?.

Am I an idiot? I believe I've thought it through, but I may be.

Click here to read the rest of this post.

Related Videos
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Leesha Ellis-Cox: Steps to Closing the Bipolar Disorder Diagnosis Gap for Blacks
Daniel Greer, PharmD: Reduction in Rehospitalizations with Antipsychotic Injections for Schizophrenia
Understanding the Link Between Substance Use and Psychiatric Symptoms, with Randi Schuster, PhD
Andrew Miller, PhD: Inventor of KarXT Discusses Pivotal EMERGENT-2 Data
© 2024 MJH Life Sciences

All rights reserved.